Survival in Primary (Idiopathic) Osteomyelofibrosis, so-called Agnogenic Myeloid Metaplasia

References

• Jacobsen R. J., Salo A., Fialkow P. J. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 1978; 51: 189–194
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H., Rabellino M., Yen A., Nachman R. L., Moore M. A. S. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 1981; 57: 781–787
   PubMed Web of Science ®Google Scholar
• Greenberg B. R., Woo L., Veomett I. C., Payne C. M., Ahmann F. R. Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis. British Journal of Haematology 1987; 66: 487–490
   PubMed Web of Science ®Google Scholar
• Adams J. A., Barrett A. J., Beard J., McCarthy D. M. Primary polycythaemia, essential thrombocythaemia and myelofibrosis-three facets of a single disease process. Acta Haematologica 1988; 79: 33–37
   PubMed Web of Science ®Google Scholar
• Geary C. G. Clinical and hematological aspects of chronic myelofibrosis. Myelofibrosis, pathophysiology and clinical management, S. M. Lewis. Marcel Dekker, New York 1985; 15–49
   Google Scholar
• Linman J. W., Bethell F. H. Agnogenic myeloid metaplasia. American Journal of Medicine 1957; 22: 107–122
   PubMed Web of Science ®Google Scholar
• Pitcock J. A., Reinhard E. H., Justus B. W., Mendelsohn R. S. A clinical and pathological study of seventy cases of myelofibrosis. Annals of Internal Medicine 1962; 57: 73–84
   PubMed Web of Science ®Google Scholar
• Bouroncle B. A., Doan C. A. Myelofibrosis: clinical, hematologic and pathologic study of 110 patients. American Journal of Medical Sciences 1962; 243: 697–715
   PubMed Web of Science ®Google Scholar
• Silverstein M. N., Gomes M. R., Re Mine W. H., Elveback L. R. Agnogenic myeloid metaplasia: natural history and treatment. Archive of Internal Medicine 1967; 120: 546–550
   PubMed Web of Science ®Google Scholar
• Rosenthal D. S., Moloney W. S. Myeloid metaplasia: a study of 98 cases. Postgraduate Medicine 1969; 45: 136–142
   PubMed Web of Science ®Google Scholar
• Ward H. P., Block M. H. The natural history of agnogenic myeloid metaplasia. Medicine. 1971; 50: 357–420
   PubMed Web of Science ®Google Scholar
• Chelloul N., Jacquillat P., Briere J., Laval-Jeantet J. P., Vorhauer-Atlan W. Valeur prognostique des lesions osteo-medullaires de splenomegalie myeloide primitive. Nou-velle Presse Medicate 1975; 43: 3060–3062
   Google Scholar
• Silverstein M. N. Agnogenic myeloid metaplasia. Publishing Science, Acton, Mass 1975
   Google Scholar
• Monoharan A., Smart R. C., Pitney W. R. Prognostic factors in myelofibrosis. Pathology 1982; 14: 455–461
   PubMed Web of Science ®Google Scholar
• Njoku O. S., Lewis S. M., Catovsky D., Gordon-Smith E. C. Anemia in myelofibrosis: its value in prognosis. British Journal of Haematology. 1983; 54: 79–89
   PubMed Web of Science ®Google Scholar
• Lohmann T. P., Beckman E. N. Progressive myelofibrosis in agnogenic myeloid metaplasia. Archives of Pathology and Laboratory Medicine 1983; 107: 593–594
   PubMed Web of Science ®Google Scholar
• Varki A., Lottenberg R., Griffith R., Reinhard E. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine 1983; 62: 353–371
   PubMed Web of Science ®Google Scholar
• Wolf B. C., Neiman R. S. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 1985; 65: 803–809
   PubMed Web of Science ®Google Scholar
• Thiele J., Zankovich R., Steinberg T., Fischer R., Diehl V. Agnogenic myeloid metaplasia (AMM)—Correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients. Hematological Oncology 1989; 7: 327–343
   PubMed Web of Science ®Google Scholar
• Anger B., Seidler R., Haug U., Popp C., Heimpel H. Idiopathic myelofibrosis: a retrospective study of 103 patients. Haematologica 1990; 75: 228–234
   PubMedGoogle Scholar
• Hasselbach H. Idiopathic myelofibrosis: a clinical study of 80 patients. American Journal of Hematology 1990; 34: 291–300
   PubMed Web of Science ®Google Scholar
• Hasselbach H. Idiopathic myelofibrosis: a review. European Journal of Haematology 1990; 45: 65–72
   PubMed Web of Science ®Google Scholar
• Hasselbach H., Jensen B. A. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance. European Journal of Haematology 1990; 44: 172–178
   PubMed Web of Science ®Google Scholar
• Meytes D., Katz D., Ramot B. Prognostic parameters in myeloid metaplasia: agnogenic versus post-polycythemic. Israel Journal of Medical Science 1976; 12: 534–540
   PubMedGoogle Scholar
• Najean Y., Cacchione R., Castro-Malaspina H., Dresch C. Erythrokinetic studies in myelofibrosis -their significance for prognosis. British Journal of Haematology. 1978; 40: 205–217
   PubMed Web of Science ®Google Scholar
• Barosi G., Berzuini C., Liberator L. N., Costa A., Polino G., Ascari E. A prognostic classification of myelofibrosis with myeloid metaplasia. British Journal of Haematology 1988; 70: 397–401
   PubMed Web of Science ®Google Scholar
• Thiele J., Steinberg T., Zankovich R., Fischer R. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis. Anticancer Research 1989; 9: 429–436
   PubMed Web of Science ®Google Scholar
• Ederer F., Axtell L. M., Cutler S. J. The relative survival rate: a statistical methodology. National Cancer Institute Monograph 1961; 6: 101–121
   PubMedGoogle Scholar
• Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 32: 933–942
   Web of Science ®Google Scholar
• Lewis S. M. Myelofibrosis: historical perspective. Myelofibrosis, pathophysiology and clinical management, S. M. Lewis. Marcel Dekker, New York 1985; 1–13
   Google Scholar
• Buyssens N., Bourgois N. H. Chronic myelocytic leukemia versus idiopathic myelofibrosis: a diagnostic problem in bone marrow biopsies. Cancer 1977; 40: 1548–1561
   PubMed Web of Science ®Google Scholar
• Burkhardt R., Bartl R., Jäger K., Frisch B., Kettner B., Mahl G., Sund M. Chronic myeloproliferative disorders (CMPD). Pathology Research and Practice 1984; 1: 31–186
   Google Scholar
• Frisch B., Bartl R., Burkhardt R., Jäger K., Mahl G., Sund G., Kettner G. Classification of myeloproliferative disorders by bone marrow histology. Bihliolheca Haematologica (Basel) 1984; 50: 57–80
   PubMedGoogle Scholar
• Georgii A., Vykoupil K. F., Thiele J. Histopathology of bone marrow and clinical findings in chronic myeloproliferative disorders. Pathology of the bone marrow, K. Lennert, K. Hubner. Fischer Verlag, Stuttgart. New York 1984; 147–169
   Google Scholar
• Frisch B., Bartl R. Histology of myelofibrosis and osteosclerosis. Myelofibrosis, pathophysiology and clinical management, S. M. Lewis. Marcel Dekker, New York 1985; 51–86
   Google Scholar
• Thiele J., Simon K.-G., Fischer R., Zankovich R. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical courses in 40 patients. Pathology Research and Practice. 1988; 183: 434–445
   PubMed Web of Science ®Google Scholar
• Thiele J., Höppner B., Zankovich R., Fischer R. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metapla-sia)-correlations between laboratory and morphological features. Virchows Archil A Pathological Anatomy and Htstopathology. 1989; 415: 191–202
   PubMed Web of Science ®Google Scholar
• Georgii A., Vykoupil K. K., Buhr T., Choritz H., Dohler U., Kaloutsi V., Werner M. Chronic myeloproliferative disorders in bone marrow biopsies. Pathology Research and Practice 1990; 186: 3–27
   PubMed Web of Science ®Google Scholar
• Hakama M., Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. Journal of Chronic Diseases 1977; 30: 585–597
   PubMedGoogle Scholar
• Jamshidi K., Swaim W. R. Bone marrow biopsy with unaltered architecture: a new biopsy device. Journal of Laboratory and Clinical Medicine. 1971; 77: 335–342
   PubMed Web of Science ®Google Scholar
• Schaefer H. E. How to fix, decalcify and stain paraffin embedded bone marrow biopsies. Pathology of the bone marrow, K. Lennert, K. Hiibner. Fischer Verlag, Stuttgart, New York 1984; 6–9
   Google Scholar
• Fisher R. A. Statistical methods for research workers. Oliver and Boyd, Edinburgh 1972
   Google Scholar
• Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Hakulinen T., Tenkanen L., Abeywickrama K. H., Paiviirinta L. Testing equality of relative survival patterns based on aggregated data. Biometries 1987; 43: 313–325
   PubMed Web of Science ®Google Scholar
• Rozman C., Giralt M., Feliu E., Rubio D., Cortes M. T. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991; 67: 2658–2663
   PubMed Web of Science ®Google Scholar
• Schafer A. I. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1–12
   PubMed Web of Science ®Google Scholar
• Silverstein M. N., Linman J. W. Causes of death in agnogenic myeloid metaplasia. Mavo Clinic Proceedings 1969; 44: 36–39
   PubMed Web of Science ®Google Scholar
• Lewis S. M., Szur L. Malignant myelosclerosis. British Medical Journal 1963; 2: 472–477
   PubMedGoogle Scholar
• Hertenstein B., Kurrle E., Frickhofen N., Heil G., Heimpel H. Aggressive polychemotherapy for acute myelofibrosis. European Journal of Haematology 1990; 44: 213–219
   PubMed Web of Science ®Google Scholar
• Wolf B. C., Neiman R. S. Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematologic Pathology 1987; 1: 77–80
   PubMedGoogle Scholar
• Wolf B. C., Luevano E., Neiman R. S. Evidence that the human fetal spleen is not a hematopoietic organ. American Journal of Clinical Pathology 1983; 80: 140–144
   PubMed Web of Science ®Google Scholar